References
- Third National Cancer Survey. Incidence data. DHEW Publ. No. (NIH) 75-787. NCI monograph. Bethesda, National Cancer Institute, 1975, p. 41.
- Icard P., Chapuis Y., Andreassian B., Bernard A., Proye C. Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery, 1992, 112: 972.
- Wooten M. D., King D. K. Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and review of the literature. Cancer, 1993, 72: 3145–55.
- Pommier R. F., Brennan M. F. An eleven-year experience with adrenocortical carcinoma. Surgery, 1992, 62: 963–70.
- Harrison L. E., Gaudin P. B., Brennan M. F. Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection. Arch Surg, 1999, 134: 181–5.
- Khorram-Manesh A., Ahlman H., Jansson S. et al. Adrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up. World J Surg, 1998, 22: 605–11.
- Crucitti F., Bellantone R., Ferrante A., Boscherini M., Crucitti P. The Italian Registry for adrenal cortical carcinoma: analysis of a multiinstitutional series of 129 patients. Surgery, 1996, 119: 161–70.
- Lockhart M. E., Smith J. K., Kenney P. J. Imaging of adrenal masses. Eur J Radiol, 2002, 41: 95–112.
- Wick M. R., Cherwitz D. L., McGlennen R. C., Dehner L. P. Adrenocortical carcinoma: an immunohistochemical comparison with renal cell carcinoma. Am J Pathol, 1986, 122: 343–52.